BRAIN | Publication-derived Organoid
Mariani Cerebral Organoids 2012
BN·DS·12 Source Mariani et al., 2012 · <UNKNOWN> · 10.1073/pnas.1202944109
⏱ 70 days 🧫 Patient-Derived iPSC (Autism/Schizophrenia risk variant carriers) 📋 Full SOP · 7 phases
NeurodevelopmentalDisease modellingDevelopmental biology +2
RETINA | Publication-derived Organoid
Koukourakis Retinal Organoids 2022
RT·DS·22 Source Koukourakis et al., 2022 · TU Dresden (Laboratory for Measurement and Sensorsystem Technique, Competence Center for Biomedical Laser Systems) · 10.37188/lam.2022.023
⏱ 231 days 🧫 Human iPSC 📋 Full SOP · 9 phases
NeurodegenerativeDisease modellingCharacterisation +1
BRAIN | Publication-derived Bioprinted / EHT
Andersen Cerebral Organoids 2025
BN·DS·25 Source Andersen et al., 2025 · Department of Neurosurgery, Odense University Hospital, University of Southern Denmark · 10.1186/s40478-025-02008-w
⏱ 210 days 🧫 Patient-Derived iPSC (Meningioma) 📋 Full SOP · 6 phases
Drug screeningDisease modellingRegenerative medicine +2
INTESTINAL | Publication-derived Tumouroid
Wigerninck Intestinal Organoids 2014
IN·DS·14 Source Wigerninck et al., 2014 · University Medical Center Utrecht, Department of Pediatric Gastroenterology, Wilhelmina Children's Hospital · 10.1053/j.gastro.2014.04.002
⏱ 230 days 🧫 Patient-Derived iPSC (Microvillus Inclusion Disease) 📋 Full SOP · 9 phases
Disease modellingiPSCPatient iPSC line
BRAIN | Publication-derived Organoid
Renner Cerebral Organoids 2020
BN·DS·20 Source Renner et al., 2020 · Max Planck Institute for Molecular Biomedicine, Münster, Germany · 10.7554/elife.52904
⏱ 59 days 🧫 Patient-Derived iPSC (from same line as smNPCs, human midbrain-specific neural precursor cells) 📋 Full SOP · 11 phases
Healthy / normalDrug screeningSafety & toxicology +3
LIVER | Publication-derived Organoid
Eugène Hepatic Organoids 2025
LV·DS·25 Source Eugène, 2025 · Université de Montréal · 10.3389/fimmu.2019.02694
⏱ 25 days 🧫 Human iPSC 📋 Full SOP · 10 phases
InfectionDisease modellingDevelopmental biology +2
LIVER | Publication-derived Organoid
Liu Hepatic Organoids 2025
LV·DS·25 Source Liu et al., 2025 · State Key Laboratory of Drug Regulatory Science, National Institutes for Food and Drug Control, Beijing, China · 10.1136/gutjnl-2025-336105
⏱ 60 days 🧫 Human iPSC 📋 Full SOP · 10 phases
InfectionDrug screeningDisease modelling +3
INTESTINAL | Publication-derived Organoid
Drost & Jaarsveld Intestinal Organoids 2015
IN·CA·15 Source Drost et al., 2015 · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht · 10.1038/nature14415
⏱ 70 days 🧫 Human small intestinal and colon stem cells from endoscopic biopsies 📋 Full SOP · 8 phases
CancerGeneticDisease modelling +1
BRAIN | Publication-derived Organoid
Bowles Cerebral Organoids 2021
BN·DS·21 Source Bowles et al., 2021 · Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai · 10.1016/j.cell.2021.07.003
⏱ 180 days 🧫 Patient-Derived iPSC (tau-V337M frontotemporal dementia) 📋 Full SOP · 4 phases
NeurodegenerativeGeneticDisease modelling +2
BRAIN | Publication-derived Organoid
Azzarelli Cerebral Organoids 2021
BN·DS·21 Source Azzarelli et al., 2021 · Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge · 10.1242/bio.056416
⏱ 42 days 🧫 Human iPSC (BobC, FSPS-13B, IMR-90) and Patient-Derived GSCs (GCGR-E27, GCGR-E35) 📋 Full SOP · 5 phases
CancerDisease modellingAdult / somatic stem +2
BRAIN | Publication-derived Organoid
Thomas Cerebral Organoids 2017
BN·DS·17 Source Thomas et al., 2017 · University of California, San Diego · 10.1016/j.stem.2017.07.009
⏱ 60 days 🧫 Human ESC and Patient-Derived iPSC (Aicardi-Goutières syndrome) 📋 Full SOP · 17 phases
GeneticInflammatoryDisease modelling +4
LIVER | Publication-derived Organoid
Hu Hepatic Organoids 2018
LV·DS·18 Source Hu et al., 2018 · Hubrecht Institute, KNAW, Utrecht, the Netherlands · 10.1016/j.cell.2018.11.013
⏱ 140 days 🧫 Mouse primary hepatocytes; Human fetal hepatocytes (11-20 weeks gestation); Human primary hepatocytes (pediatric and adult) 📋 Full SOP · 7 phases
Injury & regenerationDrug screeningDisease modelling +5
MUSCLE | Publication-derived Organoid
Gao Skeletal Muscle Organoids 2024
MU·DS·24 Source Gao et al., 2024 · Westlake University, Hangzhou, Zhejiang, China · 10.1016/j.celrep.2024.113892
⏱ 105 days 🧫 Patient-Derived iPSC (C9orf72-ALS) 📋 Full SOP · 5 phases
NeurodegenerativeDisease modellingiPSC +1
BRAIN | Publication-derived Organoid
Ghatak Cerebral Organoids 2019
BN·DS·19 Source Ghatak et al., 2019 · The Scripps Research Institute, Department of Molecular Medicine · 10.7554/elife.50333
⏱ 60 days 🧫 Patient-Derived iPSC (Familial Alzheimer's Disease - PS1 ΔE9, PS1 M146V, APP Swedish) 📋 Full SOP · 13 phases
NeurodegenerativeDisease modellingCharacterisation +2
ESOPHAGEAL | Publication-derived Organoid
Li Esophageal Organoids 2018
ES·DS·18 Source Li et al., 2018 · MRC Cancer Unit, University of Cambridge · 10.1038/s41467-018-05190-9
⏱ 7 days 🧫 Patient-Derived Cancer Tissue (Esophageal Adenocarcinoma) 📋 Full SOP · 8 phases
Drug screeningDisease modellingCharacterisation +3
BRAIN | Publication-derived Organoid
Choi Cerebral Organoids 2020
BN·DS·20 Source Choi et al., 2020 · Department of Biochemistry and Biomedical Sciences, College of Medicine, Seoul National University · 10.1111/acel.13081
⏱ 70 days 🧫 Patient-Derived iPSC (Alzheimer's disease) 📋 Full SOP · 9 phases
NeurodegenerativeDrug screeningDisease modelling +2
BRAIN | Publication-derived Organoid
Essen Cerebral Organoids 2025
BN·CA·25 Source van Essen et al., 2025 · Nuffield Department of Clinical Neurosciences, University of Oxford Medical Sciences Division · 10.1093/noajnl/vdae218
⏱ 60 days 🧫 Human iPSC-derived cerebellar organoids co-cultured with SHH-MB cell lines (DAOY, ONS-76) 📋 Full SOP · 5 phases
CancerDisease modellingCharacterisation +1
BRAIN | Publication-derived Organoid
Lee Cerebral Organoids
BN·DS·XX Source Lee et al. · Department of Anatomy, Brain Korea 21 Plus Program for Biomedical Science, Korea University College of Medicine, Seoul, Republic of Korea · 10.1101/2020.12.02.409177;
⏱ 140 days 🧫 Human ESC (H9-GFP) and Human iPSC (#5-1, #56-2, AICS-0023) 📋 Full SOP · 5 phases
Healthy / normalDrug screeningSafety & toxicology +4
BRAIN | Publication-derived Organoid
Wulansari Cerebral Organoids 2021
BN·DS·21 Source Wulansari et al., 2021 · Hanyang University · 10.1126/sciadv.abb1540
⏱ 50 days 🧫 Human ESC 📋 Full SOP · 8 phases
NeurodegenerativeGeneticDisease modelling +2
BRAIN | Publication-derived Organoid
Kang Cerebral Organoids 2021
BN·DS·21 Source Kang et al., 2021 · Emory University School of Medicine · 10.1038/s41593-021-00913-6
⏱ 71 days 🧫 Patient-Derived iPSC (Fragile X Syndrome) 📋 Full SOP · 8 phases
NeurodevelopmentalGeneticDisease modelling +2